Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Sulfacetamide sodium 100mg, prednisolone sodium phosphate 2.5mg; per mL; contains thimersol.
Various generic manufacturers
Indications for Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution:
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
Adults and Children:
<6yrs: not established. ≥6yrs: instill 2 drops in the eye(s) every 4 hours. Max initial ℞: 20mL.
Ocular fungal, viral or mycobacterial infections.
Do not inject into the eye. Corneal or scleral thinning. Severe dry eye. Glaucoma. Monitor IOP, and for secondary infections in prolonged use. Discontinue if sensitization reaction occurs. Reevaluate if symptoms fail to improve after two days. Pregnancy (Cat.C). Nursing mothers: not recommended.
Incompatible with silver preparations. Local anesthetics related to p-aminobenzoic acid may antagonize the action of sulfonamide.
Antibacterial + steroid.
Local irritation, sensitization, masks infection, delays healing; in prolonged use: increased IOP, cataracts, corneal perforation, optic nerve damage.
Formerly known under the brand name Vasocidin.
Endocrinology Advisor Articles
- Soluble Klotho Levels Predictive of Kidney Failure in Type 2 Diabetes
- Clinicians May Be Overtreating Older Patients With Diabetes
- Comorbid and Pharmacologic Factors Increase Risk for Gastrointestinal Disorders in Diabetes
- Obesity Risk in Infants Born to Women With Diabetes
- Increased Risk for Mortality in People With Diabetes, CHD Taking Beta-Blockers
- Diabetes May Decrease Ability to Feel Acid Regurgitation
- Autism Does Not Affect Metabolic Control in Type 1 Diabetes
- Hormonal Contraceptives May Adversely Affect Psychological Health in Adolescent Girls
- Obesity Can Negatively Effect Liver in Children as Young as 8
- Recommendations Developed on Gender Equity in Medicine